MedDataX Logo

Investigation of Dual-Task Exercise's Effect in Parkinson's Disease

NCT ID: NCT06803212

Last Updated: 2025-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-28

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to investigate the effects of dual-task training on upper extremity motor functions in patients with Parkinson's disease. A total of 32 patients participated in the study. Patients were divided into two groups by randomization. One group received only conventional physiotherapy applications, while the other group performed dual-task exercises in addition. Dual-task exercises were performed while conventional treatment was applied. The treatment program was applied as 60x5x6 min/day/week.

Conventional treatment was determined according to the individual needs of the patients, including the lower and upper extremities. Dual-task interventions included performing such as counting backward, word recall, and reading words backward.

Assessments were repeated twice: Baseline and after a 30-session. "Demographic Information", "Movement Disorder Society (MDS)-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)", "Box and Block Test" and "Parkinson Disease Questionnaire (PDQ-39) were used as assessment tools.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional Therapy

This group were performed just conventional physiotherapy.

Group Type ACTIVE_COMPARATOR

Conventional Physiotherapy Program

Intervention Type OTHER

The patients' conventional physiotherapy program included stretching, strengthening, balance, and coordination exercises according to their individual needs

Dual-Task Interference

Dual-task exercises were applied during conventional physiotherapy practices.

Group Type EXPERIMENTAL

Conventional Physiotherapy Program

Intervention Type OTHER

The patients' conventional physiotherapy program included stretching, strengthening, balance, and coordination exercises according to their individual needs

Dual-Task Interference

Intervention Type OTHER

This intervention consisted of counting backward, reading words backward, and remembering word exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional Physiotherapy Program

The patients' conventional physiotherapy program included stretching, strengthening, balance, and coordination exercises according to their individual needs

Intervention Type OTHER

Dual-Task Interference

This intervention consisted of counting backward, reading words backward, and remembering word exercises.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 50-85 years with a diagnosis of Stage 1-3 Parkinson's disease, based on the Hoehn \& Yahr Scale
* Patients had to have no issues with performing basic mathematical operations, - A Mini-Mental State Examination (MMSE) score above 24 points,
* Regular medication use for at least 4 weeks (for patients who were prescribed medical treatment),
* No comorbid neurological, neuromuscular, or orthopedic diseases

Exclusion Criteria

* Patients with vision or hearing impairments,
* Moderate-to-severe fluctuations in tremor or dyskinesia,
* Having deep brain stimulator implants, or sensory loss in the upper extremities.
Minimum Eligible Age

50 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emre Şenocak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emre Şenocak

Assistant Professor (PhD)

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

İstanbul Tıp Merkezi

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/109

Identifier Type: -

Identifier Source: org_study_id